Fig. 3From: A prognostic nomogram for stage II/III rectal cancer patients treated with neoadjuvant chemoradiotherapy followed by surgical resectionROC curves and AUC values of the nomogram for the predicted 24-, 36-, and 60-month OS rates for the training cohort (A–C) and the validation cohort (D–F). AUC area under the curve, ROC receiver operating characteristic, OS overall survivalBack to article page